MiniMed to begin trading on Nasdaq Global Select Market

Rhea-AI Summary

MiniMed Group (Nasdaq: MMED) began trading March 6, 2026 on the Nasdaq Global Select Market following an oversubscribed IPO.

The offering was described as the second largest IPO in medtech history and positions MiniMed to operate as a standalone company, while supporting Medtronic (NYSE: MDT)'s capital-focus strategy amid geopolitical market uncertainty.

Positive

• MiniMed began trading on Nasdaq Global Select Market under ticker MMED
• Offering was oversubscribed, indicating strong investor demand
• Described as the second largest IPO in medtech history
• Transaction supports Medtronic refocusing capital toward long‑term value creation

Negative

• Offering occurred amid a challenging market backdrop driven by geopolitical uncertainty

GALWAY, Ireland, March 6, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on the Nasdaq Global Select Market (Nasdaq) under the ticker symbol "MMED" in connection with its initial public offering ("IPO").

"Today marks an exciting milestone for both MiniMed and Medtronic. Despite a challenging market backdrop shaped by geopolitical uncertainty, the teams successfully executed an oversubscribed offering and the second largest IPO in Medtech history," said Geoff Martha, Medtronic chairman and chief executive officer. "Establishing MiniMed as a standalone entity positions the company to operate with greater agility over the long term. At the same time, this transaction supports Medtronic's strategy to focus capital and resources on long term value creation opportunities that leverage our scale, synergies, and core competencies. We congratulate Que Dallara and our Diabetes colleagues whose leadership and dedication made this moment possible."

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.

Medtronic Contacts

Justin Paquette
Public Relations
+1-612-271-7935

Ingrid Goldberg
Investor Relations
+1-763-505-2696

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/minimed-to-begin-trading-on-nasdaq-global-select-market-302706699.html

SOURCE Medtronic plc

FAQ

What does MiniMed (MMED) beginning trading on Nasdaq mean for investors?

MiniMed (MMED) is now an independent, publicly traded company on Nasdaq Global Select Market. According to the company, the IPO creates standalone equity for MiniMed while allowing Medtronic (MDT) to reallocate capital and focus on long-term value creation.

Was the MiniMed IPO oversubscribed and how significant was it for medtech?

Yes, the IPO was oversubscribed and ranked as the second largest in medtech history. According to the company, strong demand enabled the successful execution despite a challenging geopolitical market backdrop.

How does the MiniMed IPO affect Medtronic (MDT)'s strategy and capital allocation?

Medtronic says the transaction lets it concentrate capital and resources on core opportunities. According to the company, spinning off MiniMed supports a strategy to leverage scale and synergies while focusing on long-term value creation.

What ticker symbol will MiniMed trade under and when did trading start?

MiniMed will trade under the ticker MMED on the Nasdaq Global Select Market. According to the company, trading began on March 6, 2026 following the completion of its initial public offering.

Who leads MiniMed and which Medtronic executives commented on the IPO?

Que Dallara and the Diabetes leadership team were recognized for leading MiniMed. According to the company, Medtronic CEO Geoff Martha commented on the milestone and the strategic rationale for the transaction.